Entrega

Entrega is a biotechnology company focused on developing a proprietary platform for the oral delivery of biologics, such as peptides and proteins, which are typically administered via injection. Founded by PureTech Health and co-founded by Dr. Robert Langer, the company utilizes a specialized delivery technology designed to protect drugs from degradation in the digestive tract and facilitate their absorption into the bloodstream. Entrega's primary focus is on transforming the treatment landscape for chronic conditions like diabetes and obesity by enabling oral versions of injectable therapies. The company has established a significant multi-year collaboration with Eli Lilly to apply its technology to Lilly's pipeline of large molecules. This partnership includes upfront payments and potential milestones exceeding $160 million.